Policy and Legislation

Members of the HELP Committee are criticizing drugmakers for charging more for inhalers in the U.S. than in other countries.

Hospitalizations for COVID-19 have increased 20% since mid-November, according to the CDC.

The disincentive structure proposed is excessive and threatens the financial viability of economically fragile hospitals, AHA says. 

<p>Various agencies are regulating different aspects of AI, says Bryant Godfrey, partner at Foley Hoag.<br />  </p>

Rebates bring down prices by as much as half.

<p><em><strong>Note:</strong> Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice.

<p>The Trusted Exchange Framework and Common Agreement is now live, but the challenge is FHIR in TEFCA, says Don Rucker, chief strategy officer for 1upHealth and former national coordinator for Health IT at HHS.</p>

<p>FDA regulatory attorney Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, helps companies control their risk.</p> <p> </p>

<p>The AI landscape for health information technology is changing quickly, says Tom Hallisey, digital health strategy lead for the Healthcare Association of New York State.<br />  </p>

A merger between competitors that increases concentration and consolidates a market may substantially lessen competition, agencies say.